Skip to main content

Table 2 Comparison of T-SPECT results in breast cancer patients that either received (Yes) or not (No) cardiotoxic adjuvant chemotherapy.

From: Myocardial perfusion imaging with 99 mTc - tetrofosmin SPECT in breast cancer patients that received postoperative radiotherapy: a case-control study

MPI Left Breast
Cancer
Right Breast
Cancer
All Breast
Cancer
  Yes No p Yes No p Yes No p
SSS 2.9 ± 3.5 4.7 ± 3.5 0.34 5.2 ± 2.4 3.1 ± 3.1 0.31 3.6 ± 3.3 4.0 ± 3.4 0.83
SRS 1.2 ± 1.9 2.0 ± 2.6 0.46 1.2 ± 1.6 0.6 ± 0.6 0.32 1.2 ± 1.7 1.4 ± 2.1 0.97
ASSS 1.8 ± 3.6 3.1 ± 3.4 0.45 3.6 ± 0.5 1.1 ± 1.3 0.32 2.4 ± 3.1 2.2 ± 2.8 0.74
S-RSS 1.7 ± 1.9 2.6 ± 2.6 0.40 4.0 ± 3.5 2.5 ± 2.7 0.60 2.4 ± 2.6 2.6 ± 2.6 0.79
  1. Cardiotoxic chemotherapy included Adriamycin in 2 patients and Epirubicin in 14 patients; MPI: myocardial perfusion imaging; SSS: summed stress score; SRS: summed rest score; ASSS: anterior wall stress score; S-RSS: the difference of SSS minus the SRS.